ADARx Pharmaceuticals, Inc.

ADRX

Healthcare Biotechnology

13.23 0.06 −0.45%
Market cap
$1.5B
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
—
Dividend safety
n/a
Columns are period end dates · fundamentals updated 7 Oct 2026